Opioid Resource Center
Commentary
Will a cocaine epidemic follow the opioid crisis?
Dr. Michael L. Wenzinger and Dr. Mark S. Gold warn that, in light of the brain changes caused by cocaine use, a focus on prevention is imperative...
Conference Coverage
A call for ‘changing the social norms’ on naloxone
SAN DIEGO – Among individuals with a history of injection drug use, more than one-third reported never or sometimes carrying naloxone, while just...
Conference Coverage
Do free meals to physicians affect opioid prescribing?
SAN DIEGO – Physicians who received 1 free meal made about 150 opioid claims; those who received more than 10 made more than 700 claims.
From the Journals
DEA ruling may have stoked illicit opioid sales
A new study finds a strong link between making prescription opioids harder to get and a surge in dark web sales.
FDA/CDC
Generic versions of Suboxone approved for opioid dependence
The FDA says patients who receive medication-assisted treatment for opioid use disorder reduce their risk of death from all causes by 50%.
Conference Coverage
Mobile app engages individuals with opioid use disorders
Participants’ scores on the medication-assisted treatment attitudes scale rose from a mean of 3.3 to a mean of 3.5 (P = 0.044).
Conference Coverage
High-dose opioid prescribing linked to heroin use risk among U.S. veterans
SAN DIEGO – High-dose opioid prescribing is associated with an increased risk of heroin use among U.S. veterans, an observational study showed.
From the Journals
NIH launches HEAL Initiative to combat opioid crisis
HEAL will expand Advancing Clinical Trials in Neonatal Opioid Withdrawal Syndrome (ACT NOW), a pilot study that will assess the prevalence of...
Feature
AMA: Opioid prescriptions down since 2013
Number of providers registered for prescription drug monitoring programs has tripled since 2014.
Conference Coverage
Drug-related deaths continue to rise in United States
TORONTO – As pregnant women use more opioids, NAS rates are soaring; they rose from 1.2/1,000 U.S. hospital births in 2000 to 8/1,000 in 2014.
From the Journals
Subcutaneous buprenorpine rivals sublingual for opioid use disorder
Randomized trial shows noninferiority of the long-acting option for OUD that might improve adherence.